EichorEICHOR
Location: Zenica Synced from ClinicalTrials.gov · August 10, 2026

Clinical studies recruiting near Zenica

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Evaluate Pharmacokinetics (PK) and Safety of Subcutaneous (SC) Ublituximab Administered at Various Injection
Phase 2 · TG Therapeutics Investigational Trial Site · TG Therapeutics, Inc. · NCT07503873A Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB12 (Proposed Pembrolizumab Biosimilar) to
Phase 3 · Site 103003 · mAbxience Research S.L. · NCT06687369A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Phase 2 · Cantonal Hospital Zenica, Department of Internal Medicine · Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli · NCT06226883A Study of Aumolertinib in European Participants With Non-Small Cell Lung Cancer
Phase 1 · Cantonal Hospital Zenica, Crkvice 67 · Jiangsu Hansoh Pharmaceutical Co., Ltd. · NCT07130916
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.